Axsome: Q4 Earnings Snapshot

NEW YORK (AP) — NEW YORK (AP) — Axsome Therapeutics Inc. (AXSM) on Monday reported a loss of $61.2 million in its fourth quarter.

On a per-share basis, the New York-based company said it had a loss of $1.41. Losses, adjusted for non-recurring costs and amortization costs, were $1.28 per share.

The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.18 per share.

The biopharmaceutical company posted revenue of $24.4 million in the period, which topped Street forecasts. Eight analysts surveyed by Zacks expected $21.5 million.

For the year, the company reported that its loss widened to $187.1 million, or $4.60 per share. Revenue was reported as $50 million.

Axsome shares have fallen 21% since the beginning of the year. The stock has more than doubled in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on AXSM at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up